MedTrace Logo

Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds

NCT07414368 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-04-28

No results posted yet for this study

Summary

The purpose of this observational case series is to assess the use of Corplex P as a resorbable particulate device used to cover, protect, and provide a moist wound environment when added to the standard of care treatment of hard-to-heal wounds.

Conditions

  • Chronic Ulcers
  • Diabetic Foot Ulcers (DFU)
  • DFU
  • Ulcer

Interventions

DEVICE

Corplex P is used to cover, protect, and provide a moist wound environment

Corplex P is derived from human birth tissue and used in wound management to cover, protect, and provide a moist wound environment.

Sponsors & Collaborators

  • StimLabs

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-11
Primary Completion
2026-06-30
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07414368 on ClinicalTrials.gov